Clinical Trials in Denver

Showing 10481-10500 of 18,161 trials

A Study in Male and Female Subjects With Androgenetic Alopecia Treated With ATI-50002 Topical Solution

NCT03495817

Open label study to assess safety, tolerability, and efficacy of ATI-50002 in male and female subjects with androgenetic alopecia.

Androgenetic Alopecia

Aclaris Therapeutics, Inc.31 participantsStarted Mar 2018

Denver, Colorado, United States • Portland, Oregon, United States • Austin, Texas, United States

COMPLETEDPhase 3< 1 mile

Optimal Treatment for Women With a Persisting Pregnancy of Unknown Location

NCT02152696

This is a randomized controlled trial to compare three currently available management strategies for women with a persisting pregnancy of unknown location (PPUL), which makes them at-risk for ectopic pregnancy. We will recruit hemodynamically stable women with a confirmed PPUL to be randomized to one of three strategies: 1) Uterine evacuation followed by methotrexate (MTX) for some (those that have evidence of a non visualized ectopic pregnancy) 2) Empiric treatment with MTX for all 3) Expectant management. Randomization will be 1:1:1 into these three arms. After randomization, they will be followed and treated clinically as is indicated by the progression of their condition. Primary outcome measures: uneventful decline of hCG to 5 IU/mL.

Persistent Pregnancy of Unknown LocationEctopic Pregnancy

Yale University255 participantsStarted Jul 2014

San Francisco, California, United States • Denver, Colorado, United States • New Haven, Connecticut, United States +14 more locations

A Study in Male and Female Subjects With Androgenetic Alopecia Treated With ATI-50002 Topical Solution

Optimal Treatment for Women With a Persisting Pregnancy of Unknown Location

Find Trials by Condition in Denver

Feasibility of a Single-operator Peroral Cholangiopancreatioscopy System (SpyGlass)

Study of Epratuzumab Versus Placebo in Subjects With Moderate to Severe General Systemic Lupus Erythematosus (SLE)

Twenty-Four Month Extension Study of BA058-05-003 (Abaloparatide) in Participants With Osteoporosis

A Phase 2 Study to Evaluate the Safety, Efficacy, Pharmacokinetics and Pharmacodynamics of PF-06252616 in Duchenne Muscular Dystrophy

Levofloxacin in Preventing Infection in Young Patients With Acute Leukemia Receiving Chemotherapy or Undergoing Stem Cell Transplantation

A Study of MEK162 and AMG 479 in Patients With Selected Solid Tumors

Single and Multiple Dose Escalation Study to Assess the Safety and Tolerability of CJM112 in Psoriasis

An Efficacy and Safety Study of BG00011 in Participants With Idiopathic Pulmonary Fibrosis

Safety, Tolerability, and Efficacy Study of CLL442 in Patients With Cutaneous Squamous Cell Carcinoma in Situ (SCCis)

Investigate Effect of Secukinumab on the PK of Midazolam in Patients With Mod to Sev Plaque Psoriasis

A Study to Investigate Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of BKM120 Plus GSK1120212 in Selected Advanced Solid Tumor Patients

Pharmacokinetics of Dabrafenib in Subjects With Hepatic Impairment

Exploratory Study of KPI-121 Effect on Intra- or Subretinal Fluid Due to Retinal Vein Occlusion/Diabetic Macular Edema

Gadobutrol Pharmacokinetic and Safety Study in Pediatric Subjects Aged <2 Years (Term Newborn Infants to Toddlers 23 Months of Age Inclusive)

Clinical Study to Assess the Pharmacokinetics, Safety and Tolerability of Single and Multiple Oral Doses of AFQ056 in Children With Fragile X Syndrome (FXS)

Phase II Combination of Temsirolimus and Sorafenib in Advanced Hepatocellular Carcinoma

Zinc & Bone Health in Thalassemia: The Think Zinc Study

A Dose-escalation Pharmacokinetic Study of Intravenous ASA404 in Adult Advanced Cancer Patients With Impaired Renal Function and Patients With Normal Renal Function